{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:59:01Z","timestamp":1791467941074,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijbiomac.2026.153806","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:41:11Z","timestamp":1785307271000},"page":"153806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ROS-responsive chitosan\/hyaluronan polyelectrolyte nanogels for targeted chemo-ferroptosis therapy against breast cancer"],"prefix":"10.1016","volume":"378","author":[{"given":"An","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153806_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"45","key":"10.1016\/j.ijbiomac.2026.153806_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201802417","article-title":"Recent advances in targeted tumor chemotherapy based on smart nanomedicines","volume":"14","author":"Qin","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12935-017-0437-3","article-title":"Chemotherapy and tumor microenvironment of pancreatic cancer","volume":"17","author":"Liu","year":"2017","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153806_bb0020","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4251\/wjgo.v8.i11.786","article-title":"Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer","volume":"8","author":"Tsuchikawa","year":"2016","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153806_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12032-023-01954-6","article-title":"Chemotherapy: how to reduce its adverse effects while maintaining the potency?","volume":"40","author":"Brianna","year":"2023","journal-title":"Med. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153806_bb0030","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.cell.2023.02.038","article-title":"SnapShot: cancer chemotherapy","volume":"186","author":"Falzone","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206861","article-title":"Chemotherapy mediated by biomimetic polymeric nanoparticles potentiates enhanced tumor immunotherapy via amplification of endoplasmic reticulum stress and mitochondrial dysfunction","volume":"34","author":"Guo","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153806_bb0045","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0962-8924(01)02124-9","article-title":"Apoptosis and cancer chemotherapy","volume":"11","author":"Makin","year":"2001","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153806_bb0050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0029-7844(95)00058-Y","article-title":"Chemotherapy-induced apoptosis in epithelial ovarian cancers","volume":"85","author":"Havrilesky","year":"1995","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153806_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153806_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14728222.2022.2094762","article-title":"Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress","volume":"26","author":"De Francesco","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122710","article-title":"Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy","volume":"311","author":"Wang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0075","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0039","article-title":"Copper (II)-based nano-regulator correlates cuproptosis burst and sequential immunogenic cell death for synergistic cancer immunotherapy","volume":"28","author":"Luo","year":"2024","journal-title":"Biomater. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153806_bb0080","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1007\/s12274-023-5919-0","article-title":"Ferric iron coordinated cisplatin prodrug reprograms the immune-cold tumor microenvironment through tumor hypoxia relief for enhanced cancer photodynamic-immunotherapy","volume":"16","author":"Ma","year":"2023","journal-title":"Nano Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153806_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0095","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153806_bb0100","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/jcp.29232","article-title":"Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin","volume":"235","author":"Zhang","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8810785","article-title":"The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors","volume":"2020","author":"Zhu","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153806_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112678","article-title":"The role of non-apoptotic cell death in the treatment and drug-resistance of digestive tumors","volume":"405","author":"Yang","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0125","article-title":"Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: novel insights and perspectives","volume":"18","author":"Wang","year":"2023","journal-title":"Asian J Pharm Sci"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.153806_bb0130","article-title":"Cell death pathways: molecular mechanisms and therapeutic targets for cancer","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153806_bb0135","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1039\/D2TB02161G","article-title":"Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy","volume":"11","author":"Yin","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153806_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116074","article-title":"From synergy to resistance: navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma","volume":"170","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127254","article-title":"Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin","volume":"253","author":"Kuche","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175913","article-title":"Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy","volume":"955","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153806_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41419-023-05558-w","article-title":"SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase","volume":"14","author":"Xu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0165","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/DDDT.S443107","article-title":"Understanding sorafenib-induced cardiovascular toxicity: mechanisms and treatment implications","volume":"18","author":"Li","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153806_bb0170","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.21037\/tcr.2020.01.62","article-title":"Sorafenib sensitizes melanoma cells to vemurafenib through ferroptosis","volume":"9","author":"Tang","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153806_bb0175","article-title":"Fluorinated prodrug-engineered nano-remodeler relieves tumor hypoxia for dual-enhanced ferroptosis-immunotherapy","volume":"6","author":"Lei","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s42114-025-01402-1","article-title":"Functional artemisinin derivative-engineered nanohybrids boost ferroptosis stress-driven cancer therapy","volume":"8","author":"Wang","year":"2025","journal-title":"Adv. Compos. Hybrid Mater."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.153806_bb0185","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis","volume":"343","author":"Lipsky","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124897","article-title":"Codelivery of metformin and methotrexate with optimized chitosan nanoparticles for synergistic triple-negative breast cancer therapy in vivo","volume":"667","author":"Karimian-Shaddel","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.153806_bb0195","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.21.02051","article-title":"Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: results of the GETUG-AFU V05 VESPER trial","volume":"40","author":"Pfister","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153806_bb0200","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s13346-024-01701-y","article-title":"Magnetic and pH-responsive magnetite\/chitosan (core\/shell) nanoparticles for dual-targeted methotrexate delivery in cancer therapy","volume":"15","author":"Medina-Moreno","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153806_bb0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1099-0844(1998120)16:4<283::AID-CBF801>3.0.CO;2-E","article-title":"Methotrexate: pentose cycle and oxidative stress","volume":"16","author":"Babiak","year":"1998","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbacli.2015.01.006","article-title":"Cancer metabolism and oxidative stress: insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate","volume":"3","author":"Hess","year":"2015","journal-title":"BBA Clinical."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153806_bb0215","first-page":"6417","article-title":"Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors","volume":"34","author":"Lachaier","year":"2014","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153806_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1950","article-title":"Nanoparticle drug delivery systems responsive to tumor microenvironment: promising alternatives in the treatment of triple-negative breast cancer","volume":"16","author":"Cao","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153806_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12070630","article-title":"Stimuli-responsive nanomaterials for application in antitumor therapy and drug delivery","volume":"12","author":"Pham","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135893","article-title":"Recent advances on chitosan\/hyaluronic acid-based stimuli-responsive hydrogels and composites for cancer treatment: a comprehensive review","volume":"280","author":"Alsaikhan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153806_bb0235","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","article-title":"Targeting ROS in cancer: rationale and strategies","volume":"23","author":"Glorieux","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153806_bb0240","article-title":"Mitochondrial dynamics, ROS, and cell signaling: a blended overview","volume":"11","author":"Brillo","year":"2021","journal-title":"Life (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153806_bb0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1871520621666210608095512","article-title":"Reactive oxygen species (ROS): key components in cancer therapies","volume":"22","author":"Sahoo","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153806_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22942","article-title":"Imbalanced GSH\/ROS and sequential cell death","volume":"36","author":"Liu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153806_bb0260","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-024-03011-5","article-title":"From bench to bedside: ROS-responsive nanocarriers in cancer therapy","volume":"26","author":"Chauhan","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153806_bb0265","first-page":"101","article-title":"ROS-responsive drug delivery systems for biomedical applications","volume":"13","author":"Tao","year":"2018","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0270","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1016\/j.apsb.2024.10.015","article-title":"Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer","volume":"14","author":"Hu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0275","article-title":"Reactive oxygen species-regulating strategies based on nanomaterials for disease treatment","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.990145","article-title":"Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: recent advances","volume":"10","author":"Jia","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0285","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1007\/s12274-023-6017-z","article-title":"Therapeutic sponge prevents postoperative breast cancer recurrence by sustainably dissociating into CD44-targeted nanoplatform","volume":"17","author":"Sui","year":"2024","journal-title":"Nano Res."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0290","doi-asserted-by":"crossref","first-page":"41779","DOI":"10.1021\/acsami.2c11864","article-title":"Hyaluronan brush-like copolymers promote CD44 declustering in breast cancer cells","volume":"14","author":"Carvalho","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153806_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202270020","article-title":"Hyaluronic-acid-coated chitosan nanoparticles for insulin oral delivery: fabrication, characterization, and hypoglycemic ability","volume":"22","author":"Wu","year":"2022","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128719","article-title":"Synthesis of \u03b2-acids loaded chitosan-sodium tripolyphosphate nanoparticle towards controlled release, antibacterial and anticancer activity","volume":"257","author":"Tian","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"49","key":"10.1016\/j.ijbiomac.2026.153806_bb0305","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1039\/C5CC01937K","article-title":"Visible light-induced singlet oxygen-mediated intracellular disassembly of polymeric micelles co-loaded with a photosensitizer and an anticancer drug for enhanced photodynamic therapy","volume":"51","author":"Saravanakumar","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","article-title":"Polymer-drug conjugate therapeutics: advances, insights and prospects","volume":"18","author":"Ekladious","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0315","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1039\/C8CS00676H","article-title":"Cleavable linkers in antibody-drug conjugates","volume":"48","author":"Bargh","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2026.153806_bb0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.153806_bb0325","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1021\/acs.molpharmaceut.2c00472","article-title":"Design of ROS-responsive hyaluronic acid\u2013methotrexate conjugates for synergistic chemo-photothermal therapy for cancer","volume":"19","author":"Yun","year":"2022","journal-title":"Mol. Pharm."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026037529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026037529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:16:40Z","timestamp":1791465400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026037529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":65,"alternative-id":["S0141813026037529"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153806","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ROS-responsive chitosan\/hyaluronan polyelectrolyte nanogels for targeted chemo-ferroptosis therapy against breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153806"}}